Perimenopause: What It Is, When It Starts, and the Symptoms to Expect

Short Answer

Perimenopause is the transition your body moves through before menopause, when ovulation becomes less predictable and ovarian hormones start to swing rather than simply decline. For many women, the first clues show up in the 40s, though changes can begin earlier — sometimes in the 30s — or later. The transition averages about four years, but the timing is uneven: clinical references commonly describe a range of about 2–8 years, and some people experience a longer run-up. (Mayo Clinic)

Those hormone swings can change the rhythm of your whole system. Periods may come closer together, stretch farther apart, get heavier or lighter, or skip. Hot flashes and night sweats can wake you up; sleep can become lighter even without obvious sweating; mood may feel less stable; and brain fog can make words, focus, or short-term memory feel harder to access. Perimenopause officially ends only after 12 consecutive months without a period — that point is menopause. (Mayo Clinic)

A wearable can't diagnose perimenopause, because the diagnosis is usually clinical: it depends on your age, symptoms, bleeding pattern, and medical context, not on one hormone snapshot. In fact, follicle-stimulating hormone and other labs can fluctuate too much during this transition to give a clean yes-or-no answer for many people. But tracking sleep, resting heart rate, heart-rate variability, and cycle changes together can make the pattern visible — especially when your symptoms feel real but your blood work looks "normal." (NICE NG23)

What our own data shows

Among Welltory users who self-report perimenopause (n = 911) compared with users who do not (n = 3,234), filtered to good wearable-data quality, no single wearable number cleanly separates the two groups — resting heart rate, morning HRV score, and overnight recovery overlap almost entirely (AUC ≈ 0.53–0.59). The one measure that holds up on a like-for-like comparison is the morning recovery "battery," and it is slightly higher, not lower, in the perimenopause group (about 87 vs 84) — so wearables do not show a worse baseline. Symptoms tell a different story: brain fog is reported about twice as often (44% vs 22%) and un-restored mornings roughly twice as often (11% vs 5%), but those gaps flatten out when we compare people with the same number of other reported conditions, so they appear to track with the cluster of conditions that co-occur with perimenopause rather than perimenopause on its own. The honest read: the perimenopause burden shows up in what people feel and report, not in a clean wearable signature — which is exactly why tracking patterns over time is more useful here than any single number. (Welltory data; self-reported status, not clinical diagnoses.)

How we know this

— n = 911 Welltory users who self-report perimenopause vs 3,234 who do not, filtered to users with good wearable-data quality; wearable summaries (resting heart rate, HRV score, morning recovery "battery," stress load) and in-app symptom self-reports from the Welltory app. No metric separates the groups well (AUC ≈ 0.53–0.59; distribution overlap ~83–95%). The one like-for-like difference (morning battery, about +3.4; Cohen's d ≈ 0.24) is small and holds across strata by number of reported conditions; the larger symptom gaps (brain fog, un-restored mornings) do not survive that adjustment and are reported with that caveat. Self-report is a selector, not a diagnosis. All figures are anonymized, aggregated data; no individual user is identifiable.

Perimenopause at a glance

What perimenopause is — and what's happening to your hormones

Perimenopause is the transition around your final menstrual period — not a single day, and not just "a little less estrogen." In research, you'll often see it called the menopausal transition. One review defines it as "the period of progressive menstrual irregularity preceding a woman's final menstrual cycle and extending 12 months thereafter." (Perimenopause as an obesogenic sensitive period, PMC12818170) That last part is easy to miss: menopause is dated to your final period, but it can only be confirmed in hindsight after 12 consecutive months with no period, bleeding, or spotting. Perimenopause is the stretch leading up to that point, plus the year that proves the period really was final. (NIA)

For most people, the first noticeable signs show up in the 40s — often as cycles that suddenly get shorter, longer, heavier, lighter, or less predictable. But the window is wide. Some people notice changes in their 30s; others not until their 50s. Cleveland Clinic describes perimenopause as sometimes beginning as early as the mid-30s or as late as the mid-50s, while Mayo Clinic notes that many people first notice irregular periods sometime in their 40s. (Cleveland Clinic)

What drives it is hormonal change, but not a clean, steady decline. Your ovaries are becoming less predictable, ovulation may happen irregularly, and the brain–ovary hormone loop starts to wobble. Estrogen can drop, surge, and drop again. FSH can look high in one cycle and closer to premenopausal levels in another. That is why one blood test can feel so unsatisfying: it captures a moment, not the pattern. STRAW+10, the major staging framework for reproductive aging, also emphasizes cycle-pattern changes — not symptoms alone — when describing the menopausal transition. (PubMed)

That "rollercoaster" pattern is the reason symptoms can feel scattered: a few skipped periods, then a normal one; a month of poor sleep, then calmer weeks; hot flashes, mood shifts, brain fog, breast tenderness, or vaginal dryness that seem to arrive before you feel "old enough" for menopause. As one review puts it, perimenopause "is marked by hormonal fluctuations and associated biological, psychosocial, and lifestyle changes that can negatively affect health." (Perimenopause and Lifestyle Medicine, DOI 10.1177/15598276261449751) In plain English: your body is not failing. It is recalibrating under unstable hormone signals — and your cycle, sleep, temperature regulation, mood, and metabolism can all feel that instability.

When perimenopause starts and how long it lasts

Most women first notice perimenopause in their 40s — often when periods stop behaving like a reliable monthly signal — but the body can start this shift earlier, including in the 30s for some people. Clinically, the "usual" window is broad because perimenopause is not one switch flipping off; it is the ovaries becoming less predictable, with estrogen and progesterone rising and falling from cycle to cycle. Smoking, a family history of early menopause, some cancer treatments, and certain surgeries can move the timeline earlier, so symptoms before the expected age range are worth discussing with a clinician rather than brushing off as stress. (Mayo Clinic)

That wide timing is also why research on this life stage often studies women across a broad midlife age band. For example, one large multi-country study of vasomotor symptoms assessed "3523 women aged 40-60 years," which reflects how broadly the transition spans midlife rather than a single exact age. (Hot flashes: a potential marker of deterioration of health-related quality of life, PMID41725550)

Duration varies a lot from person to person. A commonly cited average is about four years, but some people move through perimenopause in only a few months, while others have symptoms and cycle changes for many years; clinical references often describe a range of roughly 2 to 8 years, and some NHS materials note that the transition can last up to about 10 years before periods stop altogether. (Cleveland Clinic)

Perimenopause is considered over only after the clock has run for 12 full months without a menstrual period. That 12-month mark is the definition of menopause; after that, you are postmenopausal. Until then, even if your periods are irregular or months apart, your body may still ovulate sometimes — which is one reason the transition can feel so confusing from the inside. (Mayo Clinic)

The symptoms: periods, hot flashes, sleep, mood, and cognition

Perimenopausal symptoms tend to arrive as a cluster because they share one messy driver: hormones that no longer rise and fall in a predictable monthly rhythm. A lifestyle-medicine review summarizes the core set directly: "The hormonal fluctuations and irregular ovulation can cause vasomotor symptoms (i.e., hot flashes, night sweats), sleep disturbances, mood and cognition issues, and increased risk of visceral adiposity." (DOI 10.1177/15598276261449751)

Irregular cycles. Often, your period is the first thing to change. As ovulation becomes less predictable, cycles may stretch out or come closer together; bleeding may get lighter, heavier, or skip entirely for a month and then return. This is why perimenopause can feel confusing: your body is not simply "running out" of periods in a straight line — the ovary-brain signaling loop is becoming irregular, so the calendar becomes irregular too. (Mayo Clinic)

Hot flashes and night sweats (vasomotor symptoms). These are the signature symptom. "Hot flashes are among the most common symptoms of the menopausal transition and have traditionally been considered benign and self-limiting" — though the same research notes emerging evidence that they may reflect broader neurovascular changes, not just discomfort. (PMID41725550) The commonly cited "about three-quarters" figure is reasonable but not universal: one nationally representative U.S. survey reported vasomotor symptoms in 79% of perimenopausal women, while a 2024 systematic review found 48.4%–70.6% across U.S. perimenopausal studies, depending on study design and symptom definitions. (PubMed, systematic review)

Sleep disruption. Sleep problems in this stage often ride on the back of nighttime hot flashes: your temperature-control system gets nudged, you sweat or wake, then your brain has to restart sleep. A randomized pilot of women in the transition specifically targeted "insomnia and vasomotor symptoms (VMS) in perimenopausal and postmenopausal women with insomnia disorder experiencing nocturnal vasomotor symptoms" — the point being that night sweats and broken sleep often travel together. (PMID42084929) But hot flashes are not the only route; sleep can change during perimenopause even without obvious night sweats. (Mayo Clinic)

Mood and anxiety. Emotional symptoms are common because estrogen and progesterone interact with brain systems involved in stress response, sleep, and mood regulation. "Perimenopause is characterized by pronounced fluctuations in ovarian steroids, which are associated with an increase vulnerability to anxiety symptoms" (PMC12986310), and a FIGO evidence review states plainly that "Symptoms of anxiety and depression are prevalent during the perimenopause." (DOI 10.1002/ijgo.70943) In real life, that may feel like irritability that arrives faster than usual, anxiety that feels more physical, or depressive symptoms that worsen around poor sleep and heavier symptom days.

Brain fog and cognition. Trouble focusing, losing words, walking into a room and forgetting why — these can be part of the recognized symptom cluster of the transition. (DOI 10.1177/15598276261449751) That does not mean your brain is permanently declining. Studies and reviews describe cognitive complaints during the menopause transition as common, usually subtle, and often mixed with sleep disruption, anxiety, depressive symptoms, and hot flashes. If the change is sudden, severe, worsening, or affecting safety or work in a major way, it deserves a clinician's evaluation rather than being written off as "just hormones." (PubMed)

Why hormone tests often can't confirm perimenopause — and what tracking can add

Perimenopause is not a switch. It is a moving hormonal state, which is why one blood draw can give you a false sense of certainty. FSH may be higher in one cycle and closer to a premenopausal range in another; estradiol can rise and fall instead of simply drifting downward. That is why, for otherwise healthy people aged 45 or over, NICE recommends identifying perimenopause from the clinical picture — newly started vasomotor symptoms plus changes in the menstrual cycle — rather than confirming it with routine hormone tests. NICE also advises against using estradiol, AMH, inhibin tests, antral follicle count, or ovarian volume to identify perimenopause or menopause in this age group, and limits serum FSH testing to narrower situations such as ages 40–45 with symptoms or suspected menopause under 40. (NICE NG23)

That does not mean labs are useless. It means they are not a clean "yes/no" answer for the transition itself. Your clinician may still check thyroid function, blood count, pregnancy, iron status, glucose, or other markers when symptoms are atypical, severe, early, or could point somewhere else. The point is that perimenopause is usually recognized by the pattern your body is making over time: cycles becoming shorter, longer, skipped, or unpredictable; hot flashes or night sweats; sleep disruption; mood shifts; vaginal or urinary changes. Mayo Clinic and Cleveland Clinic both describe the same practical pattern: estrogen rises and falls, ovulation becomes less predictable, periods change, and sleep problems can appear even when the experience looks different from person to person. (Mayo Clinic)

This is where consistent at-home tracking can add something useful. A wearable cannot diagnose perimenopause, and it should not replace a clinician. But it can help you bring evidence instead of a blur: "my sleep got worse," "my resting heart rate has been higher than my baseline," "my HRV changed," "my cycles are now 23 days, then 41, then 60." Sleep disturbance is a well-described part of the menopause transition, and research also uses HRV and heart-rate measures to study autonomic changes around menopausal symptoms and sleep. In real life, those signals are most helpful when they are interpreted as a personal trend, not as a standalone medical test. Welltory tracks and records your body signals; only a clinician can diagnose a condition. (PMC)

Supplements and lifestyle: what the evidence actually supports

Search interest around perimenopause is dominated by supplements, so it's worth being clear-eyed. The strongest evidence base is still lifestyle rather than pills: a review of the transition frames it as a "window of opportunity" (that is the paper's own title) and concludes that "Evidence-based lifestyle interventions can mitigate menopausal symptoms and reduce risk of chronic disease across the lifespan," across nutrition, physical activity, sleep, stress management, and social connection. (Perimenopause and Lifestyle Medicine: A Window of Opportunity, DOI 10.1177/15598276261449751) That matters because perimenopause is not just "low hormones." It is a moving endocrine state that can touch sleep, temperature regulation, mood, body composition, blood vessels, and daily recovery — so the boring basics have a larger surface area to work on.

For supplements specifically, the honest answer is narrower than the marketing. Calcium and vitamin D are best understood as bone-health nutrients: your body needs enough of both to maintain strong bones, and supplementation can make sense when diet, sun exposure, medical history, or lab results show you are not meeting your needs. They are not a proven fix for hot flashes, night sweats, irritability, or brain fog. Black cohosh is widely searched, but the Cochrane review found the evidence insufficient to support it for menopausal symptoms. Phytoestrogens and soy isoflavones are more complicated: soy foods can be part of a healthy diet, but trials of concentrated phytoestrogen products for hot flashes and night sweats have been inconsistent, and Cochrane did not find conclusive evidence strong enough to treat them as reliable symptom therapy. Multivitamins can help correct a real nutrient gap, but a "menopause multivitamin" is not the same thing as a treatment for perimenopausal symptoms. (NIAMS/NIH, Cochrane / PMC)

The reason to be skeptical is not that "natural" is bad. It is that supplement labels can sound clinical while the product has not been tested like a medication. In the U.S., the FDA does not approve dietary supplements for safety or effectiveness before they are sold, and NIH notes that supplements can cause side effects or interact with medicines. Harvard Health makes the same practical point about menopause marketing: product claims often move faster than rigorous evidence, especially for blends that promise hormonal balance, better libido, easier sleep, calmer mood, or hot-flash relief all at once. (FDA)

So the headline for the top supplement keywords is simple: talk to a clinician before starting anything, especially if you take prescription medication, have a history of breast cancer, liver disease, blood clots, abnormal bleeding, thyroid disease, or are using hormone therapy. Be extra cautious with blended "peri support" products, because if your sleep, heart rate, bleeding pattern, or mood changes after you start one, it is much harder to know which ingredient did what. And treat "best perimenopause supplement" content as marketing until it shows you high-quality human evidence for the exact ingredient, exact population, and exact outcome it claims to improve.

Weight, heart, and other changes to know about

Two shifts deserve a mention because they're common searches and clinically real. The first is body composition. During perimenopause, the scale may not move much, but fat storage can shift: during perimenopause, "women experience an expansion of visceral adipose tissue" and a reduction in gluteofemoral (hip/thigh) subcutaneous fat. (PMC12818170) That matters because visceral fat is more tightly linked with cardiometabolic risk than BMI alone can show — including risk patterns around cardiovascular disease and diabetes. In plain terms: this is not just "weight gain." It's a redistribution that can change what your heart, blood vessels, and metabolism are dealing with.

The second is muscle. Across the transition, studies show "-2.5% and -5.7% reductions in perimenopausal and postmenopausal women, respectively, compared to premenopausal women" in lean/muscle mass. (PMC12916153) This doesn't mean your body is failing. It means the tissue that helps you move, stabilize joints, store glucose, and keep daily energy demand steadier may need a stronger signal to stay: regular resistance work, enough dietary protein, and recovery. The evidence is still developing, but resistance training is consistently highlighted as a key intervention, and general adult guidelines recommend muscle-strengthening activity for all major muscle groups at least 2 days a week. (Mayo Clinic)

These aren't reasons to panic; they're reasons the lifestyle foundation pays off during this window. Protein gives muscle raw material. Strength training tells the body that muscle is still needed. Sleep and stress-load management make it easier to keep showing up for both. And if weight change is rapid, severe, or comes with new symptoms that don't feel like your usual pattern, it's worth discussing with a clinician rather than assuming it's "just hormones."

How we made it

We used AI tools to help draft and organize this article, then the Welltory team edited, fact-checked, and medically reviewed it before publication. We checked the medical framing against current clinical guidance and patient-health sources: perimenopause is the menopausal transition before menopause; symptoms can include changing periods, hot flashes or night sweats, sleep disruption, and vaginal dryness; and clinicians usually look at age, menstrual history, symptoms, and body changes rather than relying on one hormone test, because hormone levels can shift unpredictably during this stage. When cohort figures appear, they are reported only as anonymized, aggregated Welltory data, so no individual user can be identified. For this article, no Welltory cohort figure was published: a proprietary finding was prepared but withheld because our self-reported perimenopause cohort did not separate cleanly from the base once comorbidity was taken into account. (MedlinePlus)

About the authors

Data analysis by Jane Smorodnikova — the founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.

Written by Kseniia Iaroslavtseva — COO at Welltory. She reviews scientific research and turns it into structured, readable insights.

Reviewed by Anna Elitzur — Medical Advisor & Mental Health Expert. Anna holds her medical degree and reviews health content across topics for medical accuracy and consistency with current clinical guidelines and research.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data